Search Results - A. Thakurta

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    P865: BIOMARKER ANALYSIS TO SUPPORT DOSE OPTIMIZATION OF IBERDOMIDE AS MONOTHERAPY AND IN COMBINATION WITH STANDARD OF CARE TREATMENTS FOR MULTIPLE MYELOMA FROM A PHASE 1/2 TRIAL by M. Amatangelo, Y. Cheng, W. Pierceall, N. W. van de Donk, S. Lonial, M. Wang, J. Emerson, K. Hong, P. Maciag, T. Peluso, A. Gandhi, A. Thakurta

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    B07 HIGH EXPRESSION OF NUCLEAR CEREBLON IS ASSOCIATED WITH LONGER SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH IMIDS by R. Wester, M. van Duin, K.H. Lam, S.S. Couto, Y. Ren, M. Wang, T. Cupedo, B. van der Holt, H.B. Beverloo, A.L. Nigg, A. Thakurta, A.A. Waage, S. Zweegman, A. Broijl, P. Sonneveld

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  3. 3

    P412: LOW EXPOSURE, EXTENDED DOSING MIMICKING CLINICAL EXPOSURES OF ORAL AZACITIDINE SYNERGIZES WITH VENETOCLAX IN PRECLINICAL AML MODELS by D. Jeyaraju, M. Alapa, A. Polonskaia, A. Risueno Perez, R. Hurren, X. Wang, M. Gronda, A. Ahsan, C. Wang, P. Subramanyam, J. Sriganesh, A. Anand, M. Bysani Reddy, K. Ghosh, C. Kyriakopoulos, N. Lailler, C. Hartl, D. Lopes de Menezes, A. Schimmer, P. Hagner, A. Gandhi, A. Thakurta

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: